Undergraduate, University of Lausanne, Switzerland
PhD, University Hospital of Lausanne (CHUV), Switzerland
The principal objective of my work is improve our understanding of two distinct components of the dynamic between tumors and T cells: what are tumor rejection antigens and what are the T-cell features associated with better efficacy, both key questions in the development of novel personalized therapies.
Ludwig Institute for Cancer Research, Lausanne
Chemin des Boveresses 155
Épalinges, VD, CH, 1066
T (41) 21 314 06 24
F (41) 21 692 59 95